Search Results - "Huebler, Sophia P"

Impact of Neuroeffector Adrenergic Receptor Polymorphisms on Incident Ventricular Fibrillation During Acute Myocardial Ischemia by Chevalier, Philippe, Roy, Pascal, Bessière, Francis, Morel, Elodie, Ankou, Bénédicte, Morgan, Gina, Halder, Indrani, London, Barry, Minobe, Wayne A, Slavov, Dobromir, Delinière, Antoine, Bochaton, Thomas, Paganelli, Franck, Lesavre, Nathalie, Boiteux, Clément, Mansourati, Jacques, Maury, Philippe, Clerici, Gaël, Winum, Pierre François, Huebler, Sophia P, Carroll, Ian A, Bristow, Michael R

“…Background Cardiac adrenergic receptor gene polymorphisms have the potential to influence risk of developing ventricular fibrillation (VF) during…”
Get full text

An extensive β1-adrenergic receptor gene signaling network regulates molecular remodeling in dilated cardiomyopathies by Tatman, Philip D, Kao, David P, Chatfield, Kathryn C, Carroll, Ian A, Wagner, Jessica A, Jonas, Eric R, Sucharov, Carmen C, Port, J David, Lowes, Brian D, Minobe, Wayne A, Huebler, Sophia P, Karimpour-Fard, Anis, Rodriguez, Erin M, Liggett, Stephen B, Bristow, Michael R

“…We investigated the extent, biologic characterization, phenotypic specificity, and possible regulation of a β1-adrenergic receptor-linked (β1-AR-linked) gene…”
Get full text

Novel Tissue Factor Inhibition for Thromboprophylaxis in COVID-19: Primary Results of the ASPEN-COVID-19 Trial by Hess, Connie N., Hsia, Judith, Carroll, Ian A., Nehler, Mark R., Ruf, Wolfram, Morrow, David A., Nicolau, Jose C., Berwanger, Otavio, Szarek, Michael, Capell, Warren H., Johri, Shilpa, Pursley, Michael S., Gupta, Ryan, Meehan, Patrick S., Franchi, Francesco, Effron, Mark B., Marshall, Debra, Graybill, Christopher A., Huebler, Sophia P., Keuer, Thomas, Bristow, Michael R., Bonaca, Marc P.

“…Thrombo-inflammation is central to COVID-19-associated coagulopathy. TF (tissue factor), a driver of disordered coagulation and inflammation in viral…”
Get full text

Myocardial Injury and Altered Gene Expression Associated With SARS-CoV-2 Infection or mRNA Vaccination by Altman, Natasha L., Berning, Amber A., Saxon, Cara E., Adamek, Kylie E., Wagner, Jessica A., Slavov, Dobromir, Quaife, Robert A., Gill, Edward A., Minobe, Wayne A., Jonas, Eric R., Carroll, Ian A., Huebler, Sophia P., Raines, Joshua, Messenger, John C., Ambardekar, Amrut V., Mestroni, Luisa, Rosenberg, Rachel M., Rove, Jessica, Campbell, Thomas B., Bristow, Michael R.

“…[Display omitted] •Patients with biomarker, imaging, or electrocardiographic evidence of myocardial injury associated with recent COVID-19 infection exhibited…”
Get full text

Dose-limiting, adverse event–associated bradycardia with β-blocker treatment of atrial fibrillation in the GENETIC-AF trial by Abraham, William T., Piccini, Jonathan P., Dufton, Christopher, Carroll, Ian A., Healey, Jeffrey S., O’Connor, Christopher M., Marshall, Debra, Aleong, Ryan, van Veldhuisen, Dirk J., Rienstra, Michiel, Wilton, Stephen B., White, Michel, Sauer, William H., Anand, Inder S., Huebler, Sophia P., Connolly, Stuart J., Bristow, Michael R.

“…Heart failure (HF) patients with atrial fibrillation (AF) often have conduction system disorders, which may be worsened by β-blocker therapy. In a post hoc…”
Get full text